Mark N Sorial

Also affiliated with Dana-Farber Cancer Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma”.

Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

Leukemia & lymphoma/Leukemia and lymphoma(2024)10.1080/10428194.2024.2310144

N/A

0DataRank · unranked

17 citations

Mark N Sorial, Uvette Lou, Michelle Yu, Andrea Y. Delgado Medrano, Josie Ford +4 more

Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational study

Blood Neoplasia(2025)10.1016/j.bneo.2025.100075

N/A

0DataRank · unranked

1 citations

Matthew Lei, Robert Redd, Ruchi Rana, Uvette Lou, Mark N Sorial +19 more